中医药临床杂志2024,Vol.36Issue(11) :2114-2118.DOI:10.16448/j.cjtcm.2024.1117

郭利华自拟健脾益气逐水方治疗肺癌恶性胸腔积液经验

GUO Lihua's Experience in Treating Malignant Pleural Effusion of Lung Cancer with Jianpi Yiqi Zhushui Prescription

陈文凯 伍润梅 尹杰 杨小霞 郭利华
中医药临床杂志2024,Vol.36Issue(11) :2114-2118.DOI:10.16448/j.cjtcm.2024.1117

郭利华自拟健脾益气逐水方治疗肺癌恶性胸腔积液经验

GUO Lihua's Experience in Treating Malignant Pleural Effusion of Lung Cancer with Jianpi Yiqi Zhushui Prescription

陈文凯 1伍润梅 1尹杰 1杨小霞 2郭利华2
扫码查看

作者信息

  • 1. 云南中医药大学 云南 昆明 650500
  • 2. 云南省中医医院 云南 昆明 650021
  • 折叠

摘要

郭利华教授指出:恶性胸腔积液(Malignant pleural effusion,MPE)是临床中常见的并发症,肺癌引起的MPE是一种以虚为主,虚实夹杂的疾病.郭教授通过总结 30 余年的临床经验提出"培土制水、调气理肺"理论,以益气运脾、调气理肺、利水消癥为原则,着重运用调气药、健脾药,并自拟健脾益气逐水方,健脾益气、宽胸理肺、利水消癥使壅塞之肺气宣肃协调,以达气化则水湿自化之目的.此方经临床运用,确有治疗气虚饮停型MPE、改善生活质量的斐然作用.

Abstract

Professor GUO Lihua pointed out that malignant pleural effusion(MPE)is a common complication in clinical practice.MPE caused by lung cancer is a disease with deficiency as the main symptom and mixed deficiency and excess.Professor GUO Lihua proposed the theory of"cultivating soil and controlling water,regulating Qi and regu-lating lung"by summarizing more than 30 years of clinical experience.Based on the principles of invigorating Qi and moving spleen,regulating Qi and regulating lung,and promoting diuresis and eliminating symptoms,he focused on the use of Qi regulating drugs and spleen strengthening drugs,and formulated a prescription for strengthening spleen,invigorating Qi and expelling water,which can invigorate spleen,invigorate Qi,expand chest and regulate lung,and promote diuresis and eliminate symptoms to make the blocked lung Qi clear and coordinated,so as to achieve the pur-pose of Qi transformation and water and dampness transformation.This prescription has been clinically used and has a remarkable effect in treating MPE of Qi deficiency and fluid retention type and improving the quality of life.

关键词

悬饮/恶性胸腔积液/气虚水停证/郭利华

Key words

Xuanyin/malignant pleural effusion/Qi deficiency and water retention syndrome/GUO Lihua

引用本文复制引用

出版年

2024
中医药临床杂志
中华中医药学会

中医药临床杂志

影响因子:0.636
ISSN:1672-7134
段落导航相关论文